All Stories

  1. Hoisted by Their Own Petard: Defeating Immunity Protein–Mediated Bacteriocin Resistance
  2. Correction: Scharf et al. Oxford Nanopore Technology-Based Identification of an Acanthamoeba castellanii Endosymbiosis in Microbial Keratitis. Microorganisms 2024, 12, 2292
  3. Oxford Nanopore Technology-Based Identification of an Acanthamoeba castellanii Endosymbiosis in Microbial Keratitis
  4. Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial
  5. Infectious Complications in Patients with Myelodysplastic Syndromes: A Report from the Düsseldorf MDS Registry
  6. Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions
  7. Disseminated Cryptococcosis Is a Common Finding among Human Immunodeficiency Virus-Infected Patients with Suspected Sepsis and Is Associated with Higher Mortality Rates
  8. Teicoplanin-Resistant Coagulase-Negative Staphylococci: Do the Current Susceptibility Testing Methods Reliably Detect This Elusive Phenotype?
  9. Cytokine Hyperresponsiveness in Children With ETV6::RUNX1-positive Acute Lymphoblastic Leukemia After Challenge With Common Pathogens
  10. Diagnostik und Therapie organischer intraorbitaler Fremdkörper
  11. Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?
  12. Implementation of a Clostridioides difficile sentinel surveillance system in Germany: First insights for 2019–2021
  13. Spectrum and resistance in bacterial infections of the ocular surface in a German tertiary referral center 2009–2019
  14. Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021
  15. Characterization of the cagA-gene in Helicobacter pylori in Mongolia and detection of two EPIYA-A enriched CagA types
  16. Prevalence and characterization of antimicrobial resistance among gram-negative bacteria isolated from febrile hospitalized patients in central Ethiopia
  17. Detection of invasive Trichosporon asahii in patient blood by a fungal PCR array
  18. Ocular Syphilis: Experience over 11 Years at a German Ophthalmology Reference Centre
  19. High Acquisition Rate of Gram-Negative Multi-Drug Resistant Organism Colonization During Hospitalization: A Perspective from a High Endemic Setting
  20. High Rate of Multidrug-resistance Among Clinical Isolates of Gram-negative Bacteria in Hospitalized Patients With Febrile Diseases in Central Ethiopia
  21. Elimination of fosfomycin during dialysis with the Genius system in septic patients
  22. Clinical and microbiological characterization of sepsis and evaluation of sepsis scores
  23. Carriage of ESBL-producing Gram-negative bacteria by flies captured in a hospital and its suburban surroundings in Ethiopia
  24. Optimierung der mikrobiellen Diagnostik durch Einführung einer Standard Operating Procedure „Blutkulturen“ in der zentralen Notaufnahme
  25. CTX-M-9 group ESBL-producing Raoultella planticola nosocomial infection: first report from sub-Saharan Africa
  26. High rate of extended-spectrum beta-lactamase-producing gram-negative infections and associated mortality in Ethiopia: a systematic review and meta-analysis
  27. Carriage of ESBL-producing Gram-negative bacteria by houseflies captured in a hospital and its suburban surroundings in Ethiopia
  28. Steroid therapy does not affect the rate of indeterminate results with the T-SPOT.TB interferon gamma release assay
  29. Development and Assessment of a Simulator for in Vivo Confocal Microscopy in Fungal and Acanthamoeba Keratitis
  30. Carriage of ESBL-producing Gram-negative bacteria by houseflies captured in a hospital and its suburban surroundings in Ethiopia
  31. Elimination of glycopeptide antibiotics by cytokine hemoadsorption in patients with septic shock: A study of three cases
  32. Cryptococcal meningoencephalitis in an IgG2-deficient patient with multiple sclerosis on fingolimod therapy for more than five years – case report
  33. Mykotische Keratitis: Klinische Zeichen, Diagnose, Therapie
  34. Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016
  35. A proteomics approach for the identification of species-specific immunogenic proteins in the Mycobacterium abscessus complex
  36. Das Deutsche Pilz-Keratitis-Register
  37. Long-Term, Low-Frequency Cluster of a German-Imipenemase-1-Producing Enterobacter hormaechei ssp. steigerwaltii ST89 in a Tertiary Care Hospital in Germany
  38. Prevalence and characterization of azole-resistant Aspergillus fumigatus in patients with cystic fibrosis: a prospective multicentre study in Germany
  39. Lymphnode tuberculosis in a 4-year-old boy with relapsed ganglioneuroblastoma: a case report
  40. In-vitro activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae isolates recovered from hospitalized patients in Germany
  41. Tintelnotia destructans: Ein neuer Feind vor dem Tore
  42. Infectious risk stratification in multiple sclerosis patients receiving immunotherapy
  43. Animal-assisted therapy at a University Centre for Palliative Medicine – a qualitative content analysis of patient records
  44. Fusarium Keratitis in Germany
  45. Protracted Regional Dissemination of GIM-1-Producing Serratia marcescens in Western Germany
  46. A prospective multicenter evaluation of direct molecular detection of blood stream infection from a clinical perspective
  47. Species Diversity of Environmental GIM-1-Producing Bacteria Collected during a Long-Term Outbreak
  48. A prospective study of two isothermal amplification assays compared with real-time PCR, CCNA and toxigenic culture for the diagnosis of Clostridium difficile infection
  49. TB or not TB? Diagnostic difficulties in HIV-positive versus HIV-negative tuberculosis patients with an immigration background in Germany
  50. Intake of Lactobacillus reuteri Improves Incretin and Insulin Secretion in Glucose-Tolerant Humans: A Proof of Concept
  51. Detection and termination of an extended low-frequency hospital outbreak of GIM-1–producing Pseudomonas aeruginosa ST111 in Germany
  52. Rapid Detection and Immune Characterization of Mycobacterium abscessus Infection in Cystic Fibrosis Patients
  53. Characterization of a Novel Metallo-β-Lactamase Variant, GIM-2, from a Clinical Isolate of Enterobacter cloacae in Germany
  54. Tunneling and Suture of Thoracic Epidural Catheters Decrease the Incidence of Catheter Dislodgement
  55. Epidermal EGFR Controls Cutaneous Host Defense and Prevents Inflammation
  56. Genetic Characterization and Emergence of the Metallo-β-Lactamase GIM-1 in Pseudomonas spp. and Enterobacteriaceae during a Long-Term Outbreak
  57. Implant-associated localized osteitis in murine femur fracture by biofilm forming Staphylococcus aureus : A novel experimental model
  58. An emboligenic pulmonary abscess leading to ischemic stroke and secondary brain abscess
  59. The crystal structure of the CRISPR-associated protein Csn2 from Streptococcus agalactiae
  60. Invasive Aspergillosis in Pediatric Oncology Patients: A Rare Event With Poor Prognosis - Case Analysis to Plan Better Targeted Prophylactic or Therapeutic Measurement
  61. Depletion of neutrophil extracellular traps in vivo results in hypersusceptibility to polymicrobial sepsis in mice
  62. A Case of Relapsing-Remitting Neuroborreliosis? Challenges in the Differential Diagnosis of Recurrent Myelitis
  63. Diagnosis of Sexually Transmitted Diseases
  64. Use of a Commercial PCR-Based Line Blot Method for Identification of Bacterial Pathogens and themecAandvanGenes from BacTAlert Blood Culture Bottles: Table 1
  65. Echinococcus multilocularis: The impact of ionizing radiation on metacestodes
  66. German multicentre survey of the antibiotic susceptibility of Bacteroides fragilis group and Prevotella species isolated from intra-abdominal infections: results from the PRISMA study
  67. Fatal outcome of a disseminated dual infection with drug-resistant Mycoplasma hominis and Ureaplasma parvum originating from a septic arthritis in an immunocompromised patient
  68. A set of novel multiplex Taqman real-time PCRs for the detection of diarrhoeagenic Escherichia coli and its use in determining the prevalence of EPEC and EAEC in a university hospital
  69. Antimicrobial and immunoregulatory effector mechanisms in human endothelial cells. Indoleamine 2,3-dioxygenase versus inducible nitric oxide synthase
  70. Antimicrobial and immunoregulatory properties of human tryptophan 2,3-dioxygenase
  71. Cat Scratch Disease – Heterogeneous in Clinical Presentation: Five Unusual Cases of an Infection Caused by Bartonella henselae
  72. The missing link between indoleamine 2,3-dioxygenase mediated antibacterial and immunoregulatory effects
  73. Antimicrobial and immunoregulatory effects mediated by human lung cells: role of IFN-γ-induced tryptophan degradation
  74. Diagnostic and therapeutic implications of neurological complications following paediatric haematopoietic stem cell transplantation
  75. Diphtheria (D) and Tetanus (T) Antibody Values in Children with Acute Lymphoblastic Leukaemia (ALL) after Treatment According to Co-ALL 05/92
  76. Determination of the Performance of Various Root Canal Disinfection Methods after In Situ Carriage
  77. Role of Indoleamine 2,3-Dioxygenase in Antimicrobial Defence and Immuno-Regulation: Tryptophan Depletion Versus Production of Toxic Kynurenines
  78. TRENDS IN INFECTIONS IN CHILDREN WITH MALIGNANT DISEASE IN 2000: Comparison of Data of 1980/81
  79. Exchange transfusion in a preterm infant with hyperbilirubinemia, staphylococcal scalded skin syndrome (SSSS) and sepsis
  80. Immune reconstitution inflammatory syndrome (IRIS) due to Bacille Calmette Guerin (BCG) in an HIV-positive child
  81. Acute Hemorrhagic Pericarditis in a Child with Pneumonia Due to Chlamydophila pneumoniae
  82. GRA9, a new Toxoplasma gondii dense granule protein associated with the intravacuolar network of tubular membranes
  83. Inhibition of human herpes simplex virus type 2�by interferon ? and tumor necrosis factor ? is mediated by indoleamine 2,3-dioxygenase
  84. Nitric Oxide-Mediated Regulation of Gamma Interferon-Induced Bacteriostasis: Inhibition and Degradation of Human Indoleamine 2,3-Dioxygenase
  85. Blood Culture Sampling Rates at a German Pediatric University Hospital and Incidence of Invasive Pneumococcal Disease
  86. Role of Indoleamine-2,3-Dioxygenase in Alpha/Beta and Gamma Interferon-Mediated Antiviral Effects against Herpes Simplex Virus Infections
  87. Enhancement of antimicrobial effects by glucocorticoids
  88. Ocular infection caused by Mycobacterium kansasii in an AIDS patient
  89. Capreomycin in the Treatment of Atypical Mycobacterial Disease in HIV-Positive Patients
  90. Localization of indoleamine 2,3-dioxygenase in human female reproductive organs and the placenta
  91. The detergent octylglucoside neutralizes lipopolysaccharide in a specific manner
  92. The Immune System, by P. Parham
  93. Inhibition of indoleamine 2,3-dioxygenase in human macrophages inhibits interferon-γ-induced bacteriostasis but does not abrogate toxoplasmastasis
  94. Inducible anti-parasitic effector mechanisms in human uroepithelial cells: tryptophan degradation vs. NO production
  95. Protamine Enhances the Activity of Human Recombinant Interferon-γ
  96. Anti-parasitic effector mechanisms in human brain tumor cells: Role of interferon-γ and tumor necrosis factor-α